Hypertension is a chronic medical condition characterized by elevated blood pressure in the arteries. It affected an estimated 517 million people in 2014, a figure that will grow at a Compound Annual Growth Rate (CAGR) of 1.2% to 561 million in 2021 in the four Asia-Pacific (APAC) regions of China, India, Australia, and Japan. This high prevalence is a substantial contributor to healthcare costs and a major cause of morbidity. Despite this, awareness of hypertension is low among physicians, patients, and the public alike, leading to poor blood pressure control.
Major players in the anti-hypertensive drugs market are Merck & Co. Inc., Astra Zeneca Plc, Daiichi Sankyo Company Limited, Johnson & Johnson Ltd., Pfizer Inc., Novartis AG, Sanofi SA.... @@ https://bit.ly/3wtS4uh
Hypertension is a chronic medical condition characterized by elevated blood pressure in the arteries. It affected an estimated 517 million people in 2014, a figure that will grow at a Compound Annual Growth Rate (CAGR) of 1.2% to 561 million in 2021 in the four Asia-Pacific (APAC) regions of China, India, Australia, and Japan. This high prevalence is a substantial contributor to healthcare costs and a major cause of morbidity. Despite this, awareness of hypertension is low among physicians, patients, and the public alike, leading to poor blood pressure control. Enquiry @ http://www.researchbeam.com/anti-hypertensive-therapeutics-in-asia-pacific-to-2021-increasing-prevalence-of-hypertension-drives-growth-despite-weak-pipeline-market/enquire-about-report
Hypertension is a chronic medical condition characterized by elevated blood pressure in the arteries. It affected an estimated 517 million people in 2014, a figure that will grow at a Compound Annual Growth Rate (CAGR) of 1.2% to 561 million in 2021 in the four Asia-Pacific (APAC) regions of China, India, Australia, and Japan.
Hypertension is a chronic medical condition characterized by elevated blood pressure in the arteries. It affected an estimated 517 million people in 2014, a figure that will grow at a Compound Annual Growth Rate (CAGR) of 1.2% to 561 million in 2021 in the four Asia-Pacific (APAC) regions of China, India, Australia, and Japan. This high prevalence is a substantial contributor to healthcare costs and a major cause of morbidity. Despite this, awareness of hypertension is low among physicians, patients, and the public alike, leading to poor blood pressure control.
Sedentary lifestyle is a major driver for the growth of the anti-hypertensive drugs market. Consumption of junk food, lack of proper healthy and balanced diet, lack of proper sleep due to irregular work shifts have contributed to the increase in hypertension.
The Cardiovascular Disease (CVD) therapy area encompasses a range of different diseases and conditions affecting the heart and/or blood vessels. The most crucial risk factors for CVD are hypertension and dyslipidemia, which accelerate the development of atherosclerotic plaque build up within blood vessels. For more information on the research report, refer to below link:- https://www.kenresearch.com/healthcare/pharmaceuticals/global-cardiovascular-disease-drugs-market-to-2023/142623-91.html
This study forecasts that the global branded generics market revenue is likely to grow more than double by 2030. The current scenario is such that “Generic” names are more popular than the branded ones. For instance – “Amoxicillin” is a well-known drug to treat bacterial infections. However, it’s not “branded” by any means. The “branded” name is “Trimox”.
According to the latest research report by IMARC Group, The global hyperlipidemia drugs market size reached US$ 22.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 26.8 Billion by 2032, exhibiting a growth rate (CAGR) of 1.8% during 2024-2032. More Info:- https://www.imarcgroup.com/hyperlipidemia-drugs-market
Over time, aging is marked by a progressive loss of physiological integrity and function. Aging epigenetics refers to the changes in gene expression that occur naturally during a lifespan of the organism without changing the DNA sequence. Several enzymes are involved in chromatin epigenetics, which result in changes in DNA methylation and histone methylation/acetylation processes.
Intra-Dialytic Hypotension (IDH) Market : The IDH market is segmented based on location of testing, type of testing devices, and geography. Based on the type of testing devices, the market is further segmented into hospital testing devices and point-of-care (PoC) devices. Point-of-care (PoC) devices are beneficial for patients as they monitor inter- as well as intra-dialytic hypotension episodes. Currently, hospitals perform a majority of tests and would continue to hold a larger market share. Report Details@ http://www.bigmarketresearch.com/intra-dialytic-hypotension-IDH-market
The research firm Contrive Datum Insights has just recently added to its database a report with the heading global Argan Oil Market .Both primary and secondary research methodologies have been utilised in order to conduct an analysis of the worldwide Argan Oil Market . In order to provide a comprehensive comprehension of the topic at hand, it has been summed up using appropriate and accurate market insights. According to Contrive Datum Insights, this worldwide comprehensive report is broken up into several categories in order to present the data in a way that is understandable, succinct, and presented in a professional
Most often has the form of a 'double helix', which consists of two paired DNA ... Malfunctioning proteins are implicated in a number of diseases. Regulation. Structure ...
Global Branded Generics Market is expected to rise from its initial estimated value of USD 232.83 billion in 2018 to a projected value of USD 421.15 billion by 2026, registering a CAGR of 7.69% in the forecast period of 2019-2026
Bharat Book Bureau provides the report on “Global Brain Ischemia Market”, (https://www.bharatbook.com/healthcare-market-research-reports-315145/brain-ischemia-pipeline-review.html) This report provides emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.
The India pharmaceutical market is expected to exhibit a growth rate (CAGR) of 13.01% during 2023-2028. More info: https://www.imarcgroup.com/india-pharmaceutical-market
The global cardiovascular drugs market was valued at around $129 billion in 2017. North America was the largest region in the cardiovascular drugs market in 2017, accounting for nearly 40% market share. Read report https://www.thebusinessresearchcompany.com/report/cardiovascular-drugs-global-market-report-2018
The Cardiovascular Disease (CVD) therapy area encompasses a range of different diseases and conditions affecting the heart and/or blood vessels... To know more, click on the link below: https://www.kenresearch.com/healthcare/pharmaceuticals/global-cardiovascular-disease-drugs-market-to-2023/142623-91.html
Design and Analysis of Phase I Clinical Trials in Cancer Therapy Merrill J. Egorin, M.D. University of Pittsburgh Cancer Institute Modified from previous talks given ...
The following potential conflict of interest relationships are germane to my ... E. Sardine muscle concentrate extract .3 mg. F. Cold water fish, fowl poultry ...
More than one half of all persons older than 65 years have hypertension, often ... New Consensus Research Data ... Information from Chobanian AV, Bakris GL, ...
Burden of Rheumatoid Arthritis * Key Point: In the disease process of RA, there is an imbalance between proinflammatory and anti-inflammatory cytokines, with ...
UAE is an import driven market in context to medical devices. The imports of medical devices accounted for a lion share of ~% from the total revenue market in 2015. The market is observed to grow at a rapid pace of ~% by value from 2010 to 2015 owing to the expanding healthcare infrastructure in the country; both the government and private healthcare sector is investing heavily to provide country satisfactory healthcare solutions to the residents, expats, and medical tourists.
Obtained mouse strains which were completely resistant! ... In mice not man '606' aka Salvarsan. First useful anti-Spirochete. Treatment of Syphilis ...
There has been a dramatic increase in the incidence of diabetes worldwide, which has been exacerbated by the growing obesity problem across the globe. For More Details: http://bit.ly/1Am23RE
Title: Main title Author: admin Last modified by: risc116 Document presentation format: On-screen Show Other titles: Arial Constantia Calibri Wingdings PMingLiU ...
Ulcerative Colitis. ... agent for long-term management. Long-term ... further evaluation of UC and biopsies of a sigmoid colon mass with low grade dysplasia.
Reading the Holter ECG Report Premier 12 * DM Software * * DM Software * FCG CADgram The FCG takes 90 seconds of 12-Lead ECG data during the Asleep time with a slow ...
Monitoring Drug Efficacy & Toxicity - along with drug metabolism Michael E. Hodsdon, MD, PhD Associate Professor Departments of Laboratory Medicine & Pharmacology
Title: Modern Methods in Drug Discovery Subject: Target Identification and Animal Models Author: Michael Hutter Last modified by: Michael Hutter Created Date
BVS 611 Slide Deck II BVS 611 Pharmacology I Important notation for individuals taking medications for treatment of hypertension: Taking frequent or routine doses ...
AN OVERVIEW OF TECHNOLOGY TRANSFER AT THE UNIVERSITY OF BATH. Jenni Solbe & Alison Evans ... Links with venture capital firms and angel investors eg SWAIN ...
Congestive heart failure. 1IGJ. A Reverse Engineering Approach to ... and tolcapone are used as COMT inhibitors in Parkinson's disease treatment. Hypothesis: ...
Managing Risk in Early Drug Development Vice President, Drug Development Programs YalePharma 10 Year Trends in US Biomedical Research Spending Some Excuses for Poor ...
Philosophy Ask the right questions Science True Health Art Disease vs Health Is Health Lack of symptoms? The American Medical System Is The Leading Cause Of Death And ...
... research being conducted at Federal laboratories in the field of Biotechnology ... Hot Federal Biotechnologies Available for Collaboration and Licensing ...
Multidisciplinary Approaches to Herbal Usage Sara L. Warber, MD Linda Diane Feldt, RPP, NCTMB Sara Al-rawi, ND, MPH Leslie Shimp, PharmD Special thanks to Suzanna ...
Despite these challenges, medical device companies have always been adept with the latest technology and innovations happening in the sector. Keeping this in mind, we bring you the in-depth profiles of- “The 10 Most Innovative Medical Devices Companies 2018.”
I. Pharmacy and the Health Care System ... 36% more than one pharmacy. 26% skipped taking meds ... Contracts out for pharmacy service and all other providers ...
... Ph.D. Bob Levin Tom Sweeney Bill Ballas Bill possesses 23 years in healthcare marketing. ... Inc. PhARMA PPD Searle ... Feasibility questionnaire ...
1. One Year Post Exclusivity Adverse Event Review: ... Seizures reported in 0.1 %- use cautiously. Use cautiously in patients with bleeding predisposition ...
Inhibition of ACE leads to decreased systemic arteriolar resistance and mean ... from fragrant grains are fragrant noodles, biscuits, cakes, breads, popcorn, ...
Critical Appraisal of a Scientific Article on Therapy Nihal Thomas MD DNB (Endo) MNAMS FRACP (Endo) FRCP(Edin) Professor, Dept of Endocrinology, Christian Medical ...
Phar 722 Pharmacy Practice III Obesity and Weight Control Spring 2006 Study Guide for the Material on Obesity 1. For obesity, know: a. causes; b. reasons for the ...